Newer diabetes drugs and eye protection study
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial is looking at whether newer diabetes drugs (like SGLT2 inhibitors and DPP-4 inhibitors) can help protect the eyes of people with long-standing type 2 diabetes. The study focuses on preventing or slowing diabetic retinopathy, a common eye complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had type 2 diabetes for more than 5 years.
- You must be taking diabetes pills (like metformin, sulfonylureas, or newer drugs called SGLT2 inhibitors or DPP-4 inhibitors) for at least 2 to 3 years.
- You cannot have serious diabetic eye disease (called severe non-proliferative or proliferative retinopathy) at the start of the study.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of diabetes medications (GLP-1 receptor agonists and SGLT2 inhibitors) to see how they affect blood vessels in the back of the eye over time. It may help doctors understand if one drug is better for protecting your eyes.
This study looks at how images and other tests of the eye can help predict diabetic retinopathy, an eye problem caused by diabetes that can lead to vision loss. If you have diabetes, your eye health will be monitored closely. If you do not, you may participate as a healthy comparison.
This study looks at how fat and sugar levels in the blood relate to different stages of eye damage in people with type 2 diabetes. It may help find new ways to treat or prevent vision loss.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study follows people with type 2 diabetes to understand how diabetic retinopathy (an eye disease caused by diabetes) changes over time without treatment. It may help if you have no other eye issues causing new blood vessels and are not planning for certain eye procedures.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.